.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Accenture
Deloitte
US Army
Cantor Fitzgerald
Citi
Johnson and Johnson
Teva
McKesson
Harvard Business School

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,105,659

« Back to Dashboard

Summary for Patent: 4,105,659

Title: 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocines
Abstract:1,2,3,4,5,6-Hexahydro-3-lower alkenyl-6-(R.sup.1)-11-(R.sup.2)-8-hydroxy-2,6-methano-3-benzazocines, wherein R.sup.1 and R.sup.2 are hydrogen or lower alkyl, and certain ethers and esters thereof, are obtained from analogous 3-unsubstituted compounds. The products have pharmacodynamic activity and are useful as antagonists of strong analgesic agents, such as morphine and meperidine, and are useful in humans as agents for producing analgesia.
Inventor(s): Archer; Sydney (Bethlehem, NY)
Assignee: Sterling Drug Inc. (New York, NY)
Application Number:04/342,768
Patent Claim Types:
see list of patent claims
Compound;

No matches for this query

International Patent Family for Patent: 4,105,659

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria246157► Subscribe
Austria252248► Subscribe
Belgium611000► Subscribe
Brazil6134479► Subscribe
Switzerland410960► Subscribe
Germany1445153► Subscribe
Denmark103236► Subscribe
United Kingdom1000506► Subscribe
Malaysia6600127► Subscribe
Netherlands6705465► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Citi
Medtronic
McKesson
Farmers Insurance
Moodys
AstraZeneca
Cantor Fitzgerald
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot